N=140 | |
National Institute of Health Stroke Scale | |
Admittance to hospital, median (min–max) | 2 (0–24) |
Discharge from the acute care unit, median (min–max) | 1 (0–13) |
Glasgow Coma Scale | |
Admittance to hospital, median (min–max) | 15 (10–15) |
Discharge from the acute care unit, median (min–max) | 15 (10–15) |
Aetiology by TOAST | |
Large-artery atherosclerosis, N (%) | 36 (25.7) |
Cardioembolism, N (%) | 31 (22.1) |
Small-artery occlusion, N (%) | 29 (20.7) |
Other determined, N (%) | 15 (10.7) |
Undetermined, N (%) | 29 (20.7) |
Lesion location | |
Frontal, N (%) | 6 (4.3) |
Parietal, N (%) | 8 (5.7) |
Temporal, N (%) | 7 (5.0) |
Occipital, N (%) | 10 (7.1) |
Basal ganglia, N (%) | 37 (26.4) |
More than one location, N (%) | 42 (30.0) |
Lesion size | |
<1.5 cm, N (%) | 58 (41.4) |
1.5–4.0 cm, N (%) | 29 (20.7) |
>4.0 cm, N (%) | 23 (16.4) |
Lesion side | |
Left, N (%) | 53 (37.9) |
Right, N (%) | 49 (35.0) |
Bilateral, N (%) | 8 (5.7) |
Lesion not visible, N (%) | 30 (21.4) |
Barthel Index, median (min–max) | 100 (25–100) |
TOAST, Trial of Org 10 172 in acute stroke treatment.